Studying at the University of Verona
Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.
Study Plan
This information is intended exclusively for students already enrolled in this course.If you are a new student interested in enrolling, you can find information about the course of study on the course page:
Laurea magistrale in Molecular and Medical Biotechnology - Enrollment from 2025/2026The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.
1° Year
| Modules | Credits | TAF | SSD |
|---|
One course to be chosen among the followingOne course to be chosen among the followingTwo courses to be chosen among the followingThree courses to be chosen among the following2° Year activated in the A.Y. 2021/2022
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
One course to be chosen among the followingOne course to be chosen among the followingTwo courses to be chosen among the followingThree courses to be chosen among the following| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
Two courses to be chosen among the following ("Biotechnology in Neuroscience" and "Clinical proteomics" 1st and 2nd year; the other courses 2nd year only)Legend | Type of training activity (TTA)
TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.
Farming molecolare (2021/2022)
Teaching code
4S003677
Teacher
Coordinator
Credits
6
Language
English
Scientific Disciplinary Sector (SSD)
BIO/15 - PHARMACEUTICAL BIOLOGY
Period
Primo semestre dal Oct 4, 2021 al Jan 28, 2022.
Learning outcomes
The course aims to give the students notions of the use of recombinant systems for the production of biopharmaceuticals. In particular, the course will be focused on the biomolecular techniques used for the expression of recombinant proteins in prokaryotic and eukaryotic systems and the downstream processing and purification for their large-scale production. The different platforms used for the recombinant expression will be studied and compared. The different US and EU normative procedures for biopharmaceutical commercialization will be evaluated and compared. Specific examples of biopharmaceutical produced in recombinant systems and their therapeutic applications like for vaccines and antibodies will be discussed and studied.
Program
General introduction to the concept of Molecular farming
Definition of a biopharmaceuticals and drugs
•
• Route for biopharmaceuticals approval. The Clinical Trials
and the Regulatory Agencies. GMP definition Biosimilars and Bioequivalence
• Platforms for the heterologous production of recombinant proteins with a focus on the relative upstream processes
•
The main categories of biopharmaceuticals: Antibodies, Vaccines, Toxins and Hormones
•
• Heterologousexpressionofantibodies Toxin-based therapy
•
Active immunization: the vaccines
The clinical use of antibodies from pathogen defence to chronic diseases
Productionofvaccines Immunogenicity
Post-translational modifications Immunologicaltoleranceandoraltolerance
T-cells Biotechnology
The downstream processing
Production of peptides and their clinical and daignostic applications
•
•
• •
• •
• •
Techno-economic analysis for the production of recombinant proteins
Patent, Clinical Trials and Description of a Biopharmaceutical. TEA analysis development
Examination Methods
oral exam and written test
